Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 11773396 Chimeric antigen receptors targeting B-cell maturation antigen

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
Date Filed
October 6, 2022
Date of Patent
October 3, 2023
Patent Application Number
17938529
Patent Citations
‌
US Patent 11359204 Chimeric antigen receptors targeting B-cell maturation antigen
‌
US Patent 11377660 Chimeric antigen receptors targeting B-cell maturation antigen
‌
US Patent 7112715 Transgenic mouse for targeted recombination mediated by modified Cre-ER
‌
US Patent 9499629 Use of chimeric antigen receptor-modified T-cells to treat cancer
‌
US Patent 9765342 Chimeric antigen receptors targeting B-cell maturation antigen
‌
US Patent 10183993 Compositions and methods for treating cancer with anti-mesothelin immunotherapy
‌
US Patent 10550179 Compositions and methods for treating cancer with anti-mesothelin immunotherapy
‌
US Patent 10738312 Chimeric antigen receptors targeting B-cell maturation antigen
‌
US Patent 10738313 Chimeric antigen receptors targeting B-cell maturation antigen
‌
US Patent 10767184 Chimeric antigen receptors targeting B-cell maturation antigen
•••
Patent Inventor Names
James N. Kochenderfer
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
Patent Number
11773396
Patent Primary Examiner
‌
Peter J Reddig

Find more entities like US Patent 11773396 Chimeric antigen receptors targeting B-cell maturation antigen

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo
By using this site, you agree to our Terms of Service.